We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Exploring Neurodegenerative Diseases in Microgravity

Human cells.
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

AMSBIO, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments.


The aim of the ADDONISS (Ageing and Degenerative Diseases of Neurons on the ISS) project is to conduct research on neuronal cell cultures in the microgravity environment of the International Space Station (ISS). AMSBIO’s contribution to this groundbreaking endeavor includes providing the SH-SY5Y/GFP stable cell line and contributing €1000 towards the team’s funding costs while they were conducting research at the NASA laboratories.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

Selina Kanamüller, a member of WARR Space Labs student team at TUM, said “The experience of getting to conduct research in NASA laboratories has been unforgettable. Thanks to the help of AMSBIO and our extensive preparations for more than a year, everything went well.”


On the 15th of March, the experiment was successfully taken to the ISS using the SpaceX Falcon 9 launch vehicle. The WARR Space Labs team is currently evaluating the data gathered from the experiment. As the team awaits the results of the ADDONISS project, there is great anticipation for the potential contribution it may bring to Alzheimer’s research and the broader field of neurodegenerative disease research.